Gene Therapy for Rheumatoid Arthritis: Current Status and Future Prospects

Authors: Fabre, Sylvie; Apparailly, Florence

Source: BioDrugs, Volume 25, Number 6, 1 December 2011 , pp. 381-391(11)

Buy & download fulltext article:

Price: $62.95 plus tax (Refund Policy)

Abstract:

Rheumatoid arthritis (RA) was one of the earliest targets for gene therapy. Since the first clinical trial involving gene therapy in RA was initiated in 1996, eight clinical trials have been conducted assessing gene therapy in RA. Gene therapy has benefited from advances in biologics in terms of the increasing choice of novel, efficient targets to treat RA and also from the optimization of the delivery systems. Several strategies are possible; one of particular interest is local gene therapy directed to rheumatic joints, which avoids systemic vector diffusion. In this review, we discuss (i) gene therapeutic approaches that have been attempted for patients with RA, and (ii) novel strategies that are in development for delivery into patients. We analyze the advantages and disadvantages of the various approaches and how best to optimize them with regard to choosing the most promising vectors and strategies to allow for efficient, long-term, safe delivery of gene therapy in RA.

Keywords: Gene-therapies; Rheumatoid-arthritis

Document Type: Research article

Publication date: 2011-12-01